Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -12.52 Million AUD | 50.86% |
| 2023 | -25.5 Million AUD | -60.4% |
| 2022 | -15.89 Million AUD | -5.19% |
| 2021 | -15.11 Million AUD | -23512.59% |
| 2020 | -64 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 2.44 Million AUD | 100.0% |
| 2024 Q4 | -14.97 Million AUD | 0.0% |
| 2024 Q1 | 1.22 Million AUD | 108.62% |
| 2024 FY | -12.52 Million AUD | 50.86% |
| 2023 Q1 | -5.87 Million AUD | 5.41% |
| 2023 FY | -25.5 Million AUD | -60.4% |
| 2023 Q4 | -14.16 Million AUD | -100.0% |
| 2023 Q3 | -7.08 Million AUD | 39.69% |
| 2023 Q2 | -11.74 Million AUD | -100.0% |
| 2022 Q4 | -6.2 Million AUD | -100.0% |
| 2022 FY | -15.89 Million AUD | -5.19% |
| 2022 Q3 | -3.1 Million AUD | 67.96% |
| 2022 Q2 | -9.68 Million AUD | -100.0% |
| 2022 Q1 | -4.84 Million AUD | 57.91% |
| 2021 Q2 | -3.6 Million AUD | -100.0% |
| 2021 FY | -15.11 Million AUD | -23512.59% |
| 2021 Q4 | -11.51 Million AUD | -100.0% |
| 2021 Q3 | -5.75 Million AUD | -59.74% |
| 2021 Q1 | -1.8 Million AUD | 0.0% |
| 2020 FY | -64 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -3.81 Million USD | -228.092% |
| Skye Bioscience, Inc. | -37.64 Million USD | 66.716% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 119.237% |
| Nascent Biotech, Inc. | -2.08 Million USD | -500.18% |
| Qrons Inc. | -789.34 Thousand USD | -1487.369% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -2915.76% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -79.438% |
| BioStem Technologies, Inc. | -8.48 Million USD | -47.706% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1324.206% |
| CSL Limited | 2.64 Billion USD | 100.474% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 79.984% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 123.651% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1128.417% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -838.263% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1881.295% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 21.054% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 83.285% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -90.536% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -4482.94% |
| SQZ Biotechnologies Company | -79.46 Million USD | 84.232% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -333.2% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -588.254% |
| Mesoblast Limited | -87.95 Million USD | 85.754% |
| Marizyme, Inc. | -65.34 Million USD | 80.826% |
| Genus plc | 7.9 Million USD | 258.606% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -15.04% |
| Pharming Group N.V. | -10.54 Million USD | -18.789% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -477.462% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -237.71% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -41.676% |
| ContraFect Corporation | -65.15 Million USD | 80.769% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -156.441% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -625.336% |
| IMV Inc. | -36.48 Million USD | 65.658% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -55.463% |
| MultiCell Technologies, Inc. | -380.07 USD | -3296621.393% |
| ONE Bio Corp. | 8.67 Million USD | 244.409% |
| Accustem Sciences Inc. | -3.74 Million USD | -234.449% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 75.761% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -888.834% |
| Q BioMed Inc. | -2.05 Million USD | -510.589% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -235.651% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -426.272% |
| Biomind Labs Inc. | -1.21 Million USD | -931.842% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 79.021% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -303.958% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -58.544% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -542.804% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -83566.193% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -115.391% |
| GB Sciences, Inc. | -1.36 Million USD | -820.178% |
| Alpha Cognition Inc. | -13.77 Million USD | 9.023% |
| HST Global, Inc. | -146.21 Thousand USD | -8469.762% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -614.045% |
| Halberd Corporation | -79.67 Thousand USD | -15626.002% |
| Enzolytics Inc. | -2.17 Million USD | -475.6% |
| Agentix Corp. | -1.37 Million USD | -811.785% |
| Resverlogix Corp. | -3.61 Million USD | -247.087% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -295.084% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 95.753% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 12885.56% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 280.947% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -215.376% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -314.055% |
| AVAX Technologies, Inc. | -6.41 Million USD | -95.362% |
| Zenith Capital Corp. | -10.59 Million USD | -18.251% |
| Genscript Biotech Corporation | -95.47 Million USD | 86.877% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -53810.373% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -202.22% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -20630.845% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -524.894% |
| Kadimastem Ltd | -3.3 Million USD | -278.843% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1086.475% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -2738.86% |
| LadRx Corporation | 400.44 Thousand USD | 3228.997% |
| Cell Source, Inc. | -5.32 Million USD | -135.47% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1324.206% |
| NovAccess Global Inc. | -4.76 Million USD | -162.725% |
| Affymax, Inc. | -14.42 Million USD | 13.132% |
| Itoco Inc. | -1.86 Million USD | -570.406% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -182.043% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -650.74% |
| Mobile Lads Corp. | -2.26 Million USD | -453.612% |
| CytoDyn Inc. | -49.84 Million USD | 74.86% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -15753.946% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -5392.488% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1230.798% |
| SYBLEU INC | -180.3 Thousand USD | -6849.291% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -676.931% |
| International Stem Cell Corporation | -131 Thousand USD | -9464.77% |
| Bioxytran, Inc. | -4.28 Million USD | -192.753% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -22987.133% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -395.203% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 73.935% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -492.708% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1504.566% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -295.513% |
| Neutra Corp. | -233.46 Thousand USD | -5266.907% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 38.249% |
| PureTech Health plc | -65.69 Million USD | 80.928% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 41.082% |
| IXICO plc | -1.17 Million USD | -963.654% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -26.22% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 78.067% |
| CSL Limited | 2.64 Billion USD | 100.474% |
| Cellectis S.A. | -103.17 Million USD | 87.856% |